Jacobio Pharmaceuticals Group Co Lt (1167.HK)
Company Info
Highlights
HK$3.01B
HK$1.20 - HK$4.30
HK$2.05
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Jacobio Pharmaceuticals Group Co Lt, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Jacobio Pharmaceuticals Group Co Lt (1167.HK) returned 186.61% year-to-date (YTD) and 73.33% over the past 12 months.
1167.HK
186.61%
37.88%
103.35%
73.33%
N/A
N/A
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of 1167.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 11.81% | 69.01% | 60.42% | -0.00% | -5.45% | 186.61% | |||||||
| 2024 | -30.11% | -6.72% | -31.36% | 4.32% | -7.69% | -0.00% | 8.33% | -1.18% | 13.77% | -3.16% | -19.02% | -14.77% | -64.92% |
| 2023 | 22.37% | 37.03% | -17.22% | -5.23% | -14.53% | 0.00% | -21.43% | -17.53% | -16.01% | 19.38% | -0.52% | -4.74% | -30.78% |
| 2022 | -36.07% | -8.52% | -6.37% | 1.39% | -13.04% | -12.86% | -29.18% | 25.69% | -22.47% | -17.81% | 31.50% | 14.95% | -63.93% |
| 2021 | 41.60% | -0.25% | -20.10% | 18.90% | 17.63% | -2.68% | -14.57% | -0.54% | 1.52% | -5.65% | -9.49% | -9.49% | 2.40% |
| 2020 | -1.80% | -1.80% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 88, 1167.HK is among the top 12% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Jacobio Pharmaceuticals Group Co Lt (1167.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Jacobio Pharmaceuticals Group Co Lt. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Jacobio Pharmaceuticals Group Co Lt was 94.94%, occurring on Dec 24, 2024. The portfolio has not yet recovered.
The current Jacobio Pharmaceuticals Group Co Lt drawdown is 85.02%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.94% | Feb 8, 2021 | 955 | Dec 24, 2024 | — | — | — |
| -9.07% | Jan 19, 2021 | 9 | Jan 29, 2021 | 3 | Feb 3, 2021 | 12 |
| -7.22% | Dec 23, 2020 | 2 | Dec 24, 2020 | 9 | Jan 8, 2021 | 11 |
| -0.62% | Jan 14, 2021 | 1 | Jan 14, 2021 | 2 | Jan 18, 2021 | 3 |
Volatility
Volatility Chart
The current Jacobio Pharmaceuticals Group Co Lt volatility is 45.75%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Jacobio Pharmaceuticals Group Co Lt over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Jacobio Pharmaceuticals Group Co Lt, comparing actual results with analytics estimates.
Valuation
The Valuation section provides an overview of how Jacobio Pharmaceuticals Group Co Lt is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1167.HK relative to other companies in the Biotechnology industry. Currently, 1167.HK has a P/S ratio of 19.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1167.HK in comparison with other companies in the Biotechnology industry. Currently, 1167.HK has a P/B value of 3.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |